Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysisKatsuhiko Nara, Tappei Takada, Satoru Taguchi et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 13
Plasma Xanthine Oxidoreductase Activity Is Associated with a High Risk of Cardiovascular Disease in a General Japanese PopulationYuka Kotozaki, Makoto Sasaki, Mamoru Satoh et al.|International Journal of Environmental Research and Public Health|2021Cited by 13
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinomaTaketo Kawai, Haruki Kume, Yoshiaki Kurokawa et al.|Japanese Journal of Clinical Oncology|2025Cited by 7
Association between Plasma Xanthine Oxidoreductase Activity and the Renal Function in a General Japanese Population: The Tohoku Medical Megabank Community-Based Cohort StudySatoru Taguchi, Makoto Sasaki, Takahito Nasu et al.|Kidney & Blood Pressure Research|2022Cited by 6
Physical, but not laboratory, treatment‐related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysisSatoru Taguchi, Haruki Kume, Taketo Kawai et al.|International Journal of Urology|2024Cited by 4